Medium-Term Outcomes of Stent Therapy for Aortic Coarctation in Children Under 30 kg with New Generation Low-Profile Stents: A Follow-Up Study of a Single Centre Experience
Open Access
- 5 February 2024
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 45 (3) , 544-551
Abstract
We previously reported short-term outcomes for stenting of aortic coarctation (CoA) (native or re-coarctation) with newer generation low-profile stents (Valeo, Formula, and Begraft stents) in children under 30 kg. We present here the medium-term outcomes of this procedure. Retrospective review of patients weighing under 30 kg who had percutaneous stent treatments for coarctation between 2012 and 2021 was performed. Clinical and procedural data were collected; 19 patients were included. The median age at the time of procedure was 5.1 [4.1–6.4] years and median weight 21.0 [17.3–22.3] kg. One patient had a history of re-coarctation. Thirteen (68%) patients were on anti-hypertensives pre-procedure. Different types of stents were used (14 Valeo™, 4 Formula® 535, 1 BeGraft), which can all be dilated to 18 mm or larger. One patient required a 9 F sheath, all others required a 7 F sheath. The narrowest diameter in the aorta increased from a median of 3.5 [3.0–4.5] to 9.4 [8.9–9.8] mm, p < 0.001; there was a reduction in the median pressure gradient across the coarctation from 35.0 [30.0–43.0] to 5.0 [0–10.0] mmHg, p < 0.001. There were no intra-procedural complications. Follow-up was for a median of 56.0 [13.0–65.0] months. Five (26%) of patients underwent re-intervention after a median time frame of 40.0 [39.5–52.0] months; four had balloon dilation, one had repeat stent implantation. Five (26%) patients were on anti-hypertensive agent(s) post-intervention. Our single centre experience demonstrates that percutaneous stenting for coarctation of aorta in children under 30 kg, with low-profile stents, had no significant complications during the median follow-up time of 56 months. This study demonstrated that the procedure is safe and effective for short and medium-term therapy in this group of patients with a 26% re-intervention rate. A quarter of patients remained on anti-hypertensive medication post stenting, emphasizing the importance of long-term follow-up.Keywords
This publication has 26 references indexed in Scilit:
- Comparison of Surgical, Stent, and Balloon Angioplasty Treatment of Native Coarctation of the AortaJACC, 2011
- Stenting of aortic coarctation: Acute, intermediate, and long‐term results of a prospective multi‐institutional registry—Congenital cardiovascular interventional study consortium (CCISC)Catheterization and Cardiovascular Interventions, 2010
- A premounted stent that can be implanted in infants and re‐dilated to 20 mm: Introducing the Edwards Valeo LifestentCatheterization and Cardiovascular Interventions, 2009
- Coarctation Long-term Assessment (COALA): Significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic materialThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Coarctation of the aorta: Stenting in children and adultsCatheterization and Cardiovascular Interventions, 2006
- The Results of Catheter-Based Therapy Compared With Surgical Repair of Adult Aortic CoarctationJACC, 2006
- Coarctation of the aorta from fetus to adult: curable condition or life long disease process?Heart, 2005
- Results and mid–long-term follow-up of stent implantation for native and recurrent coarctation of the aortaEuropean Heart Journal, 2005
- The CP stent--short, long, covered--for the treatment of aortic coarctation, stenosis of pulmonary arteries and caval veins, and Fontan anastomosis in children and adults: an evaluation of 60 stents in 53 patientsHeart, 2005
- Natural history of coarctation of the aortaHeart, 1970